These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34433120)

  • 1. Severe granulocytopenia in a patient on long-term use of clozapine and with COVID-19.
    Pereira VC; de Stefani DZ; Braga AGO; Domingues JFR; Santos-Junior AD; Dalgalarrondo P; Banzato CEM
    Psychiatry Res; 2021 Nov; 305():114171. PubMed ID: 34433120
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels].
    Smits F; Bogers JPAM; de Leeuw M
    Tijdschr Psychiatr; 2021; 63(6):406-411. PubMed ID: 34231858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of clozapine-induced granulocytopenia associated with olanzapine.
    Flynn SW; Altman S; MacEwan GW; Black LL; Greenidge LL; Honer WG
    J Clin Psychopharmacol; 1997 Dec; 17(6):494-5. PubMed ID: 9408818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematologic effects of clozapine: a review of the international experience].
    Lamarque V
    Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine prolongation of granulocytopenia after clozapine discontinuation.
    Konakanchi R; Grace JJ; Szarowicz R; Pato MT
    J Clin Psychopharmacol; 2000 Dec; 20(6):703-4. PubMed ID: 11106146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
    Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
    Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytopenia with clozapine and quetiapine.
    Diaz P; Hogan TP
    Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
    [No Abstract]   [Full Text] [Related]  

  • 10. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
    Combs MD; Perry PJ; Bever KA
    Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP
    Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.
    Veerman SRT; Bogers JPAM; Cohen D; Schulte PFJ
    Pharmacopsychiatry; 2022 Jan; 55(1):48-56. PubMed ID: 34470068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
    J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese Population.
    Saito T; Ikeda M; Hashimoto R; Iwata N; ; Yamamori H; Yasuda Y; Fujimoto M; Kondo K; Shimasaki A; Kawase K; Miyata M; Mushiroda T; Ozeki T; Kubo M; Fujita K; Kida N; Nakai M; Otsuru T; Fukuji Y; Murakami M; Mizuno K; Shiratsuchi T; Numata S; Ohmori T; Ueno SI; Yada Y; Tanaka S; Kishi Y; Takaki M; Mamoto A; Taniguchi N; Sawa Y; Watanabe H; Noda T; Amano Y; Kimura T; Fukao T; Suwa T; Murai T; Kubota M; Ueda K; Tabuse H; Kanahara N; Kawai N; Nemoto K; Makinodan M; Nishihata Y; Hashimoto N; Kusumi I; Fujii Y; Miyata R; Hirakawa K; Ozaki N
    Biol Psychiatry; 2017 Jul; 82(1):e9-e10. PubMed ID: 28161127
    [No Abstract]   [Full Text] [Related]  

  • 15. Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopenia.
    Saito T; Ikeda M; Mushiroda T; Iwata N;
    Aust N Z J Psychiatry; 2020 May; 54(5):545-546. PubMed ID: 31968985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of clozapine-induced granulocytopenia with lithium (two observations)].
    Papetti F; Darcourt G; Giordana JY; Spreux A; Thauby S; Feral F; Pringuey D
    Encephale; 2004; 30(6):578-82. PubMed ID: 15738861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White blood cell monitoring during long-term clozapine treatment.
    Cohen D; Monden M
    Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine-induced agranulocytosis after 11 years of treatment.
    Sedky K; Shaughnessy R; Hughes T; Lippmann S
    Am J Psychiatry; 2005 Apr; 162(4):814. PubMed ID: 15800170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.